Oculis Aktie
| 21,25USD | -0,10USD | -0,47% |
WKN DE: A3D8QG / ISIN: CH1242303498
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 2 | 28 | 36 | 49 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 1 | 26 | 120 | 116 |
| Summe Anlagevermögen | 128 | 14 | 16 | 17 |
| Summe Aktiva | 128 | 40 | 136 | 133 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 8 | 146 | 25 | 52 |
| Summe Eigenkapital | 121 | -106 | 111 | 81 |
| Summe Passiva | 128 | 40 | 136 | 133 |
Adresse
| Bahnhofstrasse 20, 6300 Zug | |
| Telefon | +41 (41) 711-39-60 |
| Internet | http://www.oculis.com |
Management
|
Anthony Adam Rosenberg
Chairman |
|
Arshad M. Khanani
Director |
|
Caroline Daniere
Chief Human Resources Officer |
|
Christina Maria Ackermann
Independent Non-Executive Director |
|
Geraldine O'Keeffe
Independent Director |
|
Gudrun Bachmann
Chief Technology Officer |
|
Isabelle de Chambrier
Chief Quality Officer |
|
Lionel Carnot
Independent Director |
|
Martijn Kleijwegt
Independent Director |
|
Páll Ragnar Jóhannesson
Chief Business Officer |
|
Rebecca Weil
Chief Commercial Officer |
|
Riad Sherif
Chief Executive Officer & Director |
|
Robert K. Warner
Director |
|
Sharon Klier
Chief Development Officer |
|
Snehal Shah
President-Research & Development |
|
Sylvia Cheung
Chief Financial Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.